Activin and Inhibin

Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15 , and is used for the research of cellular proliferative diseases.In VitroKif15-IN-2 (Compound 14) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against

Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15 , and is used for the research of cellular proliferative diseases.In VitroKif15-IN-2 (Compound 14) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against

Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15 , and is used for the research of cellular proliferative diseases.In VitroKif15-IN-2 (Compound 14) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against

Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15 , and is used for the research of cellular proliferative diseases.In VitroKif15-IN-2 (Compound 14) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against

KIF18A-IN-1 is a mitotic kinesin KIF18A inhibitor extracted from patent WO2021026098A1 example 100-13. KIF18A-IN-1 exhibits anti-tumor activityForm:SolidIC50&amp: Target:mitotic kinesin KIF18A.

KIF18A-IN-1 is a mitotic kinesin KIF18A inhibitor extracted from patent WO2021026098A1 example 100-13. KIF18A-IN-1 exhibits anti-tumor activityForm:SolidIC50&amp: Target:mitotic kinesin KIF18A.

KIF18A-IN-1 is a mitotic kinesin KIF18A inhibitor extracted from patent WO2021026098A1 example 100-13. KIF18A-IN-1 exhibits anti-tumor activityForm:SolidIC50&amp: Target:mitotic kinesin KIF18A.

KIF18A-IN-1 is a mitotic kinesin KIF18A inhibitor extracted from patent WO2021026098A1 example 100-13. KIF18A-IN-1 exhibits anti-tumor activityIC50&amp: Target:mitotic kinesin KIF18A.

KIF18A-IN-2 is a potent KIF18A inhibitor ( IC 50 =28 nM). KIF18A-IN-2 causes significant mitotic arrest and increases the number of mitotic cells in tumor tissues. KIF18A-IN-2 can be used for researching cancerIn VivoKIF18A-IN-2 (compound 23) (100

KIF18A-IN-2 is a potent KIF18A inhibitor ( IC 50 =28 nM). KIF18A-IN-2 causes significant mitotic arrest and increases the number of mitotic cells in tumor tissues. KIF18A-IN-2 can be used for researching cancerIn VivoKIF18A-IN-2 (compound 23) (100

KIF18A-IN-6 (Compound 134) is an orally active KIF18A inhibitor with an IC 50 of 0.016 μM against KIF18A microtubule-dependent ATPase activityIn VitroKIF18A-IN-6 (Compound 134: 7 days) inhibits JIMT-1, HCC-15 and NIH-OVCAR3 cells viability with IC

KIF18A-IN-6 (Compound 134) is an orally active KIF18A inhibitor with an IC 50 of 0.016 μM against KIF18A microtubule-dependent ATPase activityIn VitroKIF18A-IN-6 (Compound 134: 7 days) inhibits JIMT-1, HCC-15 and NIH-OVCAR3 cells viability with IC